1 results match your criteria: "University Tor Vergata cInstitute of Cognitive Sciences and Technologies[Affiliation]"
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma?
Nucl Med Commun
January 2013
Department of Biopathology and Diagnostic Imaging, University Tor Vergata cInstitute of Cognitive Sciences and Technologies, CNR, Rome, Italy.
Objective: The aim of the study was to investigate the effect of chemotherapy treatment with ABVD on brain glucose metabolism in patients with Hodgkin's disease (HD).
Methods: A total of 49 patients (23 men, 26 women; mean age 32±9 years) diagnosed with HD were included in the study. All of them underwent a baseline (PET0) and an interim (PET2) 2-deoxy-2-[(18)F]fluoro-D-glucose ((18)F-FDG) PET/computed tomography (CT) brain scan.